Related to Trophos to Get $9.1M from AFM for Further Development of SMA Treatment

• Tulane Scores $15M to Bolster Research on Lassa Fever
  
• Horizon and University of Torino Win $500K Grant to Develop SNP-Based Cancer Models
  
• Schepens Eye Institute Receives Unrestricted Grant to Progress Retinal Stem Cell Collaboration with ReNeuron
  
• Galapagos and MorphoSys Add Fourth Target to Ongoing Alliance in Bone and Joint Diseases
  
• DeveloGen and Istituto Raffaele Win $500K JDRF Grant for R&D in Beta-Cell Regeneration
  
• SIGA Wins $2.8M DoD Contract to Progress Antiviral into the Clinic
  
• Fraunhofer USA CMB Obtains $4.4M DARPA Funding for Phase I Trials with H1N1 Vaccine
  
• Achillion Wins SBIR Grant to Evaluate Preclinical Compounds against Drug-Resistant TB
  
• Inovio Obtains $2.8M Grant to Advance Preclinical DNA Vaccines for HCV
  
• Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform
  
• Evotec Wins €1.5M in German Federal Funding to Take H3 Receptor Blocker into Clinic
  
• BioMarker Strategies Receives $1M Tranche of SBIR Funding to Develop Solid Tumor Biomarker Platform
  
• GlycoVaxyn and Brigham and Women’s Win $3.4M to Develop S. aureus Vaccine
  
• Crucell Receives $110M UNICEF Contract for Quinvaxem Pediatric Vaccine
  
• Synedgen Wins $2.73M U.S. Army Grant to Combat Drug-Resistant Bacteria
  
• EPA Issues Second Phase II Task Order of $2.9M to Caliper under Its ToxCast Program
  
• MitoSciences Nabs $590K NIH Grant to Develop Companion Diagnostics for Antivirals
  
• RegeneRx Wins $3M Award to Advance Peptide Therapeutic for Heart Attack
  
• GATC to Sequence Pediatric Brain Tumors for PedBrainTumor Consortium
  
• PDx Obtains NINDS Grant to Uncover Causative Genes for Parkinson Disease